Medtronic's InSync
This article was originally published in The Gray Sheet
Executive Summary
Cardiac stimulating device is introduced in Europe for the treatment of heart failure patients that are unresponsive to drug therapy. Using the Attain LV lead, the product is designed to synchronize the right and left sides of the heart in addition to the upper and lower chambers, the company explains. In addition, Medtronic announces the first implantation of the Chronicle implantable hemodynamic monitor at the Karolinska Hospital in Stockholm. The device provides physicians continuous, quantitative information on cardiac function